Delivery Order SPE2DB20D3101-SPE2DB22FH9T0
Award Date 3/2/22
Potential Completion Date 3/3/22
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,419.85 firm fixed-price delivery order is for the supply of Estrace 0.01% cream, a topical estrogen medication. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Estrace 0.01% Cream in 42.5 gram units. The $2,002.68 firm fixed-price delivery order is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,315.53 firm fixed price delivery order is for the pharmaceutical product Estrace 0.01% Cream, 42.5 gm. The contract has an ultimate completion date of October 21, 2024 and was awarded on October 18, 2024. This delivery order is associated with a larger $999,999,999 Indefinite Delivery...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Estrace 0.01% cream in 42.5 gram quantities. The $5,461.26 firm fixed price delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This federal contract award, with ID SPE2DB24D2101|SPE2DB25FKJSG, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,131.24 firm fixed-price delivery order is for the supply of Estrace 0.01% cream, 42.5 gm. This order is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,739.91 firm fixed-price delivery order is for the supply of Estrace 0.01% cream, a topical estrogen medication, to support federal healthcare programs. The award is part of a broader $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Estrace 0.01% cream. The $1,534.97 firm fixed-price contract has a completion date of May 25, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The contract award is...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,778.64 for the supply of Estrace 0.01% Cream 42.5GM. The award was made by the Defense Logistics Agency (DLA), a defense agency, on January 5, 2023, with a completion date of January 6, 2023. The contract has a Firm Fixed Price pricing type and does not have a set-aside designation, indicating full and open competition. Amerisourcebergen is a major pharmaceutical...
- This federal contract award is for the delivery of Estrace 0.01% cream, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,513.26, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 2, 2023. The contract has a completion date of June 5, 2023 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., holds...
- This is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, awarded to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,268.29 firm fixed price order is for the supply of ESTRACE 0.01% Cream 42.5GM, a prescription pharmaceutical product. Amerisourcebergen, a major pharmaceutical distributor, holds multiple federal contracts and IDCs to provide a wide range of medical commodities, including prescription...